Literature DB >> 19384031

Role of azithromycin against clinical isolates of family enterobacteriaceae: A comparison of its minimum inhibitory concentration by three different methods.

N Chayani1, S Tiwari, G Sarangi, B Mallick, A Mohapatra, B P Paty, P Das.   

Abstract

PURPOSE: To determine the effect of azithromycin, a new azalide antibiotic, on clinical isolates of the family Enterobacteriaceae and to determine and compare its minimum inhibitory concentration (MIC) by disk diffusion, agar dilution and E-test methods.
MATERIALS AND METHODS: One hundred fifty-nine bacterial strains belonging to the family Enterobacteriaceae, isolated from different clinical samples, were tested for their susceptibility to azithromycin by disk diffusion, agar dilution and E-test methods. The MIC values were analysed and the percentages of agreement between the different methods were mentioned.
RESULTS: Of the 159 isolates of the family Enterobacteriaceae, 60.37% were E. coli followed by Klebsiella species 28.3%, Salmonella and Shigella species 3.77% and Enterobacter and Citrobacter species 1.88% each. Maximum isolates were obtained from urine 117/159 (73.58%). Azithromycin was found to be more active against Salmonella and Shigella species, showing 100% sensitivity the by E-test and 83.33% by the disk diffusion methods. In the agar dilution method, 83.33% of Salmonella and 66.66% of Shigella species were sensitive to azithromycin. The overall agreement between disk diffusion and agar dilution method was 96.8%, between agar dilution and E-test was 88% and between disk diffusion and E-test was 91.2%.
CONCLUSION: Azithromycin may become an important addition to our antimicrobial strategies, especially for the treatment of bacterial diarrhoea and infections caused by Salmonella typhi.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384031     DOI: 10.4103/0255-0857.45361

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  6 in total

1.  Design and formulation technique of a novel drug delivery system for azithromycin and its anti-bacterial activity against Staphylococcus aureus.

Authors:  M Joyce Nirmala; Amitava Mukherjee; N Chandrasekaran
Journal:  AAPS PharmSciTech       Date:  2013-06-26       Impact factor: 3.246

2.  Enteric fever in a 6-year-old traveler caused by Salmonella enterica serotypes Typhi and Paratyphi A: laboratory detection strategies and treatment options.

Authors:  Romney M Humphries; Nava Yeganeh; Kevin W Ward; M A Lewinski; Natascha Ching
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

3.  A study of antibiogram of Salmonella enterica serovar Typhi isolates from Pondicherry, India.

Authors:  Sreenivasan Srirangaraj; Arunava Kali; M V Pravin Charles
Journal:  Australas Med J       Date:  2014-04-30

4.  First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure.

Authors:  Aoife Molloy; Satheesh Nair; Fiona J Cooke; John Wain; Mark Farrington; Paul J Lehner; M Estee Torok
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

Review 5.  Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries.

Authors:  Elizabeth A Ashley; Yoel Lubell; Nicholas J White; Paul Turner
Journal:  Trop Med Int Health       Date:  2011-06-24       Impact factor: 2.622

6.  Sensitivity Pattern Of Salmonella typhi And Paratyphi A Isolates To Chloramphenicol And Other Anti-Typhoid Drugs: An In Vitro Study.

Authors:  Niranjan Patil; Prashant Mule
Journal:  Infect Drug Resist       Date:  2019-10-14       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.